severe chronic
Showing 1 - 25 of >10,000
COVID-19, Renal Insufficiency, Chronic Trial in Beijing (Nirmatrelvir/ritonavir)
Recruiting
- COVID-19
- Renal Insufficiency, Chronic
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 6, 2023
Chronic Hand Eczema Trial (Delgocitinib, Vehicle cream)
Not yet recruiting
- Chronic Hand Eczema
- Delgocitinib
- Vehicle cream
- (no location specified)
Aug 16, 2023
COPD Trial (Nitric Oxide Generation and Delivery System)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Nitric Oxide Generation and Delivery System
- (no location specified)
Jun 1, 2023
Validate Cumulative Life Course Impairment Instrument in Adult
Not yet recruiting
- Psoriasis
- (no location specified)
Jul 17, 2023
COPD Trial (HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- HRG2005 inhalation
- +3 more
- (no location specified)
Sep 7, 2023
Pulmonary Disease, Chronic Obstructive Trial in Beijing, Shenzhen, Shanghai (611 300 mg Q2W, 611 450 mg Q2W, Matching )
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- 611 300 mg Q2W
- +2 more
-
Beijing, Beijing, China
- +2 more
Oct 25, 2023
Chronic Stroke Trial in Cleveland (motor learning based therapy, MyoPro, Home Exercise Program)
Recruiting
- Chronic Stroke
- motor learning based therapy
- +2 more
-
Cleveland, OhioLouis Stokes VA Medical Center, Cleveland, OH
Jan 31, 2023
Respiratory and Cardiovascular Alterations in Chronic
Recruiting
- Chronic Obstructive Pulmonary Disease Moderate
- +3 more
-
Kaunas, LithuaniaLithuanian University of Health Sciences
Oct 8, 2023
Hemodialysis, Chronic Pain, Hyperparathyroidism Trial in Taipei (Vitamin D, Placebo)
Not yet recruiting
- Hemodialysis
- +2 more
- Vitamin D
- Placebo
-
Taipei, TaiwanTaipei Medical University Hospital
Dec 26, 2022
Pruritus Trial in Jacksonville (Dupilumab 300Mg Solution for Injection)
Recruiting
- Pruritus
- Dupilumab 300Mg Solution for Injection
-
Jacksonville, FloridaMayo Clinic Florida
Nov 30, 2022
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)
Not yet recruiting
- Chronic Plaque Psoriasis
- Moderate to Severe Chronic Plaque Psoriasis
- Placebo
- Bimekizumab
- (no location specified)
Aug 21, 2023
Lung Disease Chronic Trial in Toronto (exoskeleton assist)
Recruiting
- Lung Disease Chronic
- exoskeleton assist
-
Toronto, Ontario, CanadaWestpark Health Care Centre
Apr 17, 2023
Moderate to Severe Chronic Plaque Psoriasis Trial (CT-P17, EU-approved Humira)
Not yet recruiting
- Moderate to Severe Chronic Plaque Psoriasis
- CT-P17
- EU-approved Humira
- (no location specified)
Aug 8, 2022
COPD Trial in Guangzhou (Ensifentrine, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Ensifentrine
- Placebo
-
Guangzhou, Guangdong, China1st Affiliated Hospital of Guangzhou Medical University
Feb 28, 2023
Hand Eczema Trial in Groningen (Dupilumab, Placebo)
Active, not recruiting
- Hand Eczema
- Dupilumab
- Placebo
-
Groningen, NetherlandsUniversity Medical Center Groningen
Aug 18, 2022
COPD Trial in Hillerød (Intervention)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Intervention
-
Hillerød, DenmarkNordsjællands Hospital
Dec 12, 2022
Moderate to Severe Chronic Plaque Psoriasis Trial in Mayfield Heights (Stelara, Bmab1200)
Recruiting
- Moderate to Severe Chronic Plaque Psoriasis
- Stelara
- Bmab1200
-
Mayfield Heights, OhioApex Clinical Research Center
Jul 14, 2022
Psoriasis Trial in Lahore (Apremilast 30mg)
Completed
- Psoriasis
- Apremilast 30mg
-
Lahore, Punjab, PakistanGhurki Hospital
Sep 5, 2023
Chronic Kidney Disease(CKD), Uncontrolled Hypertension Trial in Tours (Antihypertensive algorithm, Standard of care)
Not yet recruiting
- Chronic Kidney Disease(CKD)
- Uncontrolled Hypertension
- Antihypertensive algorithm
- Standard of care
-
Tours, FranceDepartment of Nephrology, University Hospital of Tours
Feb 8, 2023
Phenotypes in Severe Chronic Obstructive Pulmonary Disease
Completed
- Severe COPD
- NA: no intervention
- (no location specified)
Feb 25, 2022
Psoriasis Trial in Shanghai (LZM012, Secukinumab)
Recruiting
- Psoriasis
- LZM012
- Secukinumab
-
Shanghai, Shanghai, ChinaHuashan Hospital
Oct 29, 2023
Gastrointestinal Diseases, Irritable Bowel Syndrome Trial (a)standardised dietician supervised intervention, b) exercise
Not yet recruiting
- Gastrointestinal Diseases
- Irritable Bowel Syndrome
- a)standardised dietician supervised intervention, b) exercise intervention, c) internet delivered cognitive behavior therapy or d) nothing
- a) consultant-led outpatient clinic or b) a integrated care clinic
- (no location specified)
Dec 12, 2022
Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
Not yet recruiting
- Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
- IncobotulinumtoxinA
- Placebo
- (no location specified)
Oct 13, 2023
COPD Trial in China (TQC3721 suspension for inhalation, TQC3721 matching for inhalation, Salbutamol sulfate inhalation aerosol)
Recruiting
- Chronic Obstructive Pulmonary Disease
- TQC3721 suspension for inhalation
- +2 more
-
Guangzhou, Guangdong, China
- +10 more
Aug 4, 2023
COPD Severe Trial in London (Auto-titrating non-invasive ventilation)
Suspended
- Chronic Obstructive Pulmonary Disease Severe
- Auto-titrating non-invasive ventilation
-
London, United KingdomGuys and St Thomas NHS Foundation Trust
Dec 29, 2022